1.35

2.17% -0.03

After Hours: 1.37 0.02 +1.48%

Senti Biosciences Inc (SNTI)

Overview News Price History Financials Discussions Forecast

Senti Biosciences Inc stock is traded at $1.35, with a volume of 73,040. It is down -2.17% in the last 24 hours and down -8.78% over the past month. Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Previous Close:

$1.38

Open:

$1.36

24h Volume:

73,040

Relative Volume:

0.24

Market Cap:

$35.32M

Revenue:

$1.79M

Net Income/Loss:

$-70.90M

P/E Ratio:

-0.0869

EPS:

-15.54

Net Cash Flow:

$-34.95M

1W Performance:

-2.88%

1M Performance:

-8.78%

6M Performance:

-59.58%

1Y Performance:

-56.45%

1-Day Range:

$1.34

$1.38

1-Week Range:

$1.26

$1.39

52-Week Range:

$1.26

$16.94

Senti Biosciences Inc Stock (SNTI) Company Profile

Name

Senti Biosciences Inc

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(650) 239-2030

Address

2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-08-16

Latest SEC Filings

SNTI's Discussions on Twitter

Compare SNTI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SNTI Senti Biosciences Inc	1.35	34.01M	1.79M	-70.90M	-34.95M	-15.54
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-06-25	Initiated	Laidlaw	Buy
Oct-07-22	Initiated	Morgan Stanley	Equal-Weight

Senti Biosciences Inc (SNTI)

Senti Biosciences Inc Stock (SNTI) Company Profile

Compare SNTI with other stocks

Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades

Senti Biosciences Inc Stock (SNTI) Latest News

Will Senti Biosciences Inc. bounce back from current supportJuly 2025 Reactions & Consistent Return Strategy Ideas - Newser

Sentiment analysis tools applied to Senti Biosciences Inc.Quarterly Trade Review & AI Forecast for Swing Trade Picks - Newser

Is Senti Biosciences Inc. stock bottoming out2025 Big Picture & Reliable Intraday Trade Plans - Newser

How hedge fund analytics apply to Senti Biosciences Inc. stockDip Buying & Stepwise Trade Execution Plans - Newser

What to expect from Senti Biosciences Inc. in the next 30 days2025 Trading Volume Trends & Community Verified Swing Trade Signals - Newser

How moving averages guide Senti Biosciences Inc. trading2025 Price Momentum & Fast Exit Strategy with Risk Control - Newser

Volatility clustering patterns for Senti Biosciences Inc.Fed Meeting & Fast Gain Stock Trading Tips - Newser

How sentiment analysis helps forecast Senti Biosciences Inc.July 2025 Breakouts & Capital Protection Trading Alerts - Newser

What high frequency data says about Senti Biosciences Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - Newser

Senti Biosciences Inc. stock momentum explained2025 Trading Recap & Intraday High Probability Alerts - Newser

What earnings revisions data tells us about Senti Biosciences Inc.2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser

Why Senti Biosciences Inc. is moving today2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser

Senti Biosciences Inc. stock daily chart insightsTrade Risk Summary & Community Shared Stock Ideas - Newser

Using flow based indicators on Senti Biosciences Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - Newser

News impact scoring models applied to Senti Biosciences Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - Newser

Is Senti Biosciences Inc. still worth holding after the dipJuly 2025 Institutional & Weekly High Potential Stock Alerts - Newser

Published on: 2025-09-11 19:44:07 - Newser

What technical models suggest about Senti Biosciences Inc.’s comebackShort Setup & Daily Volume Surge Trade Alerts - Newser

Using Ichimoku Cloud for Senti Biosciences Inc. technicals2025 Pullback Review & Reliable Price Breakout Alerts - Newser

Order flow analysis tools used on Senti Biosciences Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser

Detecting price anomalies in Senti Biosciences Inc. with AIJuly 2025 Reactions & Safe Capital Growth Plans - Newser

How to use a screener to detect Senti Biosciences Inc. breakoutsJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser

Will Senti Biosciences Inc. benefit from macro trendsQuarterly Risk Review & Smart Money Movement Alerts - Newser

What is Senti Biosciences Inc.’s TAM (Total Addressable Market)Dollar Strength & Reliable Intraday Trade Plans - Lancaster City Council

will senti biosciences inc. bounce back from current supportShort Setup & Daily Technical Forecast Reports - Newser

Published on: 2025-09-09 04:01:38 - Newser

Senti Biosciences Inc Stock (SNTI) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to SNTI